Norsigian, Charles J.
Danhof, Heather A. http://orcid.org/0000-0002-6347-0021
Brand, Colleen K.
Oezguen, Numan http://orcid.org/0000-0002-3175-2382
Midani, Firas S. http://orcid.org/0000-0002-2473-7758
Palsson, Bernhard O. http://orcid.org/0000-0003-2357-6785
Savidge, Tor C.
Britton, Robert A.
Spinler, Jennifer K. http://orcid.org/0000-0002-7830-7665
Monk, Jonathan M. http://orcid.org/0000-0002-3895-8949
Funding for this research was provided by:
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (U01-AI124316, U01-AI124316, U01-AI124290, R01AI123278, P30-DK56338, U01-AI124290, U01-AI124290, R01AI123278, R01AI123278, R01AI123278)
Article History
Received: 12 February 2020
Accepted: 26 August 2020
First Online: 20 October 2020
Competing interests
: T.C.S. received research funding from Merck, Nivalis, Cubist, Mead Johnson, Rebiotix, BioFire, Assembly, and has served on the advisory board for Rebiotix and BioFire. The authors declare that there are no other competing interests.